Bryant D. Lim
2019 - Idera Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $155,232 |
|---|---|
| Option Awards | $150,317 |
| Salary | $336,000 |
| Stock Awards | $56,834 |
| Other | $33,412 |
| Total | $731,795 |
Lim received $336K in salary, accounting for 46% of the total pay in 2019.
Lim also received $155.2K in non-equity incentive plan, $150.3K in option awards, $56.8K in stock awards and $33.4K in other compensation.
Rankings
In 2019, Bryant D. Lim's compensation ranked 10,544th out of 13,971 executives tracked by ExecPay. In other words, Lim earned more than 24.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,544 out of 13,971 | 25th |
Division Manufacturing | 4,263 out of 5,701 | 25th |
Major group Chemicals And Allied Products | 1,653 out of 2,200 | 25th |
Industry group Drugs | 1,416 out of 1,886 | 25th |
Industry Biological Products, Except Diagnostic Substances | 316 out of 389 | 19th |
Pay ratio
| Bryant D. Lim's Pay | $731,795 |
|---|---|
| Median Employee's Pay | $278,816 |
| Pay Ratio | 3to 1 |
In 2019, the annual total compensation of Bryant D. Lim was $731,795.
The annual total compensation of the median employee at Idera Pharmaceuticals was $278,816.
The ratio of Bryant D. Lim's pay to the pay of median employee was therefore 3 to one.
Lim's colleagues
We found four more compensation records of executives who worked with Bryant D. Lim at Idera Pharmaceuticals in 2019.
2019
Vincent Milano
Idera Pharmaceuticals
Chief Executive Officer
2019
Jonathan Yingling
Idera Pharmaceuticals
Chief Scientific Officer
2019
R Fletcher
Idera Pharmaceuticals
Senior Vice President, Business Development and Strategy
2019
John Kirby
Idera Pharmaceuticals
Chief Financial Officer
News
April 26, 2024
April 28, 2021
April 6, 2020
April 25, 2019